ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring